The increasing demand for controlled immunological study and therapeutic development has spurred significant improvements in recombinant signal molecule manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently generated using diverse expression systems, including bacterial hosts, animal cell populations, an